Mathilde Debeaupte1, Evelyne Decullier, Stephane Tringali, Arnaud Devèze, Thierry Mom, Vincent Darrouzet, Eric Truy. 1. *Department of Otolaryngology, Hôpital E. Herriot, Université Lyon 1, Lyon, France; †Hospices Civils de Lyon, Pôle Information Médicale Evaluation Recherche, Unité de Recherche Clinique, Lyon, France; ‡Université de Lyon, RECIF, EAM Santé Individu Société 4128, Lyon, France; §Université Lyon 1, Lyon, France; ∥Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Département d'Oto-neurochirurgie, Pierre-Bénite, France; ¶Department of Otolaryngology, University Hospital Nord, Assistance Publique Hôpitaux de Marseille and Laboratory of Applied Biomechanics, IFSTTAR UMR T24, Aix Marseille Universités, Marseille, France; #Service ORL et Chirurgie Cervico-Faciale CHU Gabriel Montpied et laboratoire de Biophysique Neurosensorielle, INSERM UMR 1107-63000, Clermont-Ferrand, France; **ENT and Skull Base Surgery Department, Hôpital Pellegrin, Bordeaux Cedex, France; ††University of Bordeaux, Bordeaux, France; and ‡‡Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, CRNL, INSERM U1028, CNRS UMR 5292, Lyon, France.
Abstract
OBJECTIVE: To describe the reliability of the fully implantable middle ear transducer after successive technological changes. STUDY DESIGN: Prospective, observational, multicenter study. SETTING: Eight tertiary referral centers. PATIENTS: One hundred twenty-three adults were implanted with one of the five successive versions of the fully implantable middle ear implant between September 2005 and July 2012. METHODS: The reliability of each generation 2 years after implantation or at the maximal lifetime was reported by means of survival curves. Only technological failures were considered; non-technological failures were excluded from the analysis of reliability. RESULTS: One hundred fifty-seven devices were implanted during the period of study. Fifteen explantations were related to non-technological problems (e.g., infections, extrusions, etc.). One hundred forty-two implants were followed in the analysis of reliability. We observed 32 technical failures at 2 years. At the maximal lifetime of follow-up, 46 implants failed. The end of the follow-up was the first of November 2012. Survival rates at 2 years were 0%, 76.1%, 84.2%, 81.8%, and 100% for each of the successive available versions, respectively. CONCLUSION: The reliability of the fully implantable middle ear implant improved over generations thanks to successive technological modifications that corrected the observed failures. The latest generation seems to be a reliable fully implantable middle ear implant system up to 22 months after implantation. The need to know the reliability of these active middle ear implants incites the creation of a follow-up register including patient's data and device failures to improve patient management.
OBJECTIVE: To describe the reliability of the fully implantable middle ear transducer after successive technological changes. STUDY DESIGN: Prospective, observational, multicenter study. SETTING: Eight tertiary referral centers. PATIENTS: One hundred twenty-three adults were implanted with one of the five successive versions of the fully implantable middle ear implant between September 2005 and July 2012. METHODS: The reliability of each generation 2 years after implantation or at the maximal lifetime was reported by means of survival curves. Only technological failures were considered; non-technological failures were excluded from the analysis of reliability. RESULTS: One hundred fifty-seven devices were implanted during the period of study. Fifteen explantations were related to non-technological problems (e.g., infections, extrusions, etc.). One hundred forty-two implants were followed in the analysis of reliability. We observed 32 technical failures at 2 years. At the maximal lifetime of follow-up, 46 implants failed. The end of the follow-up was the first of November 2012. Survival rates at 2 years were 0%, 76.1%, 84.2%, 81.8%, and 100% for each of the successive available versions, respectively. CONCLUSION: The reliability of the fully implantable middle ear implant improved over generations thanks to successive technological modifications that corrected the observed failures. The latest generation seems to be a reliable fully implantable middle ear implant system up to 22 months after implantation. The need to know the reliability of these active middle ear implants incites the creation of a follow-up register including patient's data and device failures to improve patient management.
Authors: Nils Kristian Prenzler; Eugen Kludt; Thomas Giere; Rolf Salcher; Thomas Lenarz; Hannes Maier Journal: Biomed Res Int Date: 2019-01-06 Impact factor: 3.411